Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 164

1.

Prognostic factors of Pneumocystis jirovecii pneumonia in patients without HIV infection.

Kim SJ, Lee J, Cho YJ, Park YS, Lee CH, Yoon HI, Lee SM, Yim JJ, Lee JH, Yoo CG, Lee CT, Kim YW, Han SK, Kim HB, Park JS.

J Infect. 2014 Jul;69(1):88-95. doi: 10.1016/j.jinf.2014.02.015. Epub 2014 Mar 4.

PMID:
24607411
2.

[Investigation of Pneumocystis jirovecii in clinical specimens by different methods].

Tekinşen FF, Koç AN.

Mikrobiyol Bul. 2013 Oct;47(4):658-67. Turkish.

3.

Outcome of Pneumocystis jirovecii pneumonia diagnosed by polymerase chain reaction in patients without human immunodeficiency virus infection.

Hardak E, Neuberger A, Yigla M, Berger G, Finkelstein R, Sprecher H, Oren I.

Respirology. 2012 May;17(4):681-6. doi: 10.1111/j.1440-1843.2012.02158.x.

PMID:
22390188
4.

Multicenter, prospective clinical evaluation of respiratory samples from subjects at risk for Pneumocystis jirovecii infection by use of a commercial real-time PCR assay.

Hauser PM, Bille J, Lass-Flörl C, Geltner C, Feldmesser M, Levi M, Patel H, Muggia V, Alexander B, Hughes M, Follett SA, Cui X, Leung F, Morgan G, Moody A, Perlin DS, Denning DW.

J Clin Microbiol. 2011 May;49(5):1872-8. doi: 10.1128/JCM.02390-10. Epub 2011 Mar 2.

5.

Diagnosis of Pneumocystis jirovecii pneumonia in immunocompromised patients by real-time PCR: a 4-year prospective study.

Robert-Gangneux F, Belaz S, Revest M, Tattevin P, Jouneau S, Decaux O, Chevrier S, Le Tulzo Y, Gangneux JP.

J Clin Microbiol. 2014 Sep;52(9):3370-6. doi: 10.1128/JCM.01480-14. Epub 2014 Jul 9.

6.

Pneumocystis polymerase chain reaction and blood (1→3)-β-D-glucan assays to predict survival with suspected Pneumocystis jirovecii pneumonia.

Matsumura Y, Ito Y, Yamamoto M, Matsushima A, Nagao M, Takakura S, Iinuma Y, Ichiyama S.

J Infect Chemother. 2014 Feb;20(2):109-14. doi: 10.1016/j.jiac.2013.09.004. Epub 2013 Dec 11.

PMID:
24480550
7.

Cellular profiles of bronchoalveolar lavage fluid and their prognostic significance for non-HIV-infected patients with Pneumocystis jirovecii pneumonia.

Lee JY, Park HJ, Kim YK, Yu S, Chong YP, Kim SH, Sung H, Lee SO, Kim MN, Lim CM, Kim YS, Koh Y, Woo JH, Choi SH.

J Clin Microbiol. 2015 Apr;53(4):1310-6. doi: 10.1128/JCM.03494-14. Epub 2015 Feb 11.

8.

Quantitative PCR to diagnose Pneumocystis pneumonia in immunocompromised non-HIV patients.

Mühlethaler K, Bögli-Stuber K, Wasmer S, von Garnier C, Dumont P, Rauch A, Mühlemann K, Garzoni C.

Eur Respir J. 2012 Apr;39(4):971-8. doi: 10.1183/09031936.00095811. Epub 2011 Sep 15.

9.

[The Pneumocystis jirovecii colonization in bronchoalveolar lavage (BAL) and bronchial washing and the comparison of methods which are used in diagnosis].

Özmen A, Mıstık R, Alver O, Coşkun F, Ursavaş A, Uzaslan E.

Tuberk Toraks. 2013;61(4):303-11. Turkish.

10.

Loop-mediated isothermal amplification method for diagnosing Pneumocystis pneumonia in HIV-uninfected immunocompromised patients with pulmonary infiltrates.

Nakashima K, Aoshima M, Ohkuni Y, Hoshino E, Hashimoto K, Otsuka Y.

J Infect Chemother. 2014 Dec;20(12):757-61. doi: 10.1016/j.jiac.2014.08.005. Epub 2014 Aug 31.

PMID:
25187511
11.

Comparison of 2 real-time PCR assays for diagnosis of Pneumocystis jirovecii pneumonia in human immunodeficiency virus (HIV) and non-HIV immunocompromised patients.

Montesinos I, Brancart F, Schepers K, Jacobs F, Denis O, Delforge ML.

Diagn Microbiol Infect Dis. 2015 Jun;82(2):143-7. doi: 10.1016/j.diagmicrobio.2015.03.006. Epub 2015 Mar 12.

PMID:
25801778
12.

Real-time PCR is more specific than conventional PCR for induced sputum diagnosis of Pneumocystis pneumonia in immunocompromised patients without HIV infection.

Fujisawa T, Suda T, Matsuda H, Inui N, Nakamura Y, Sato J, Toyoshima M, Nakano Y, Yasuda K, Gemma H, Hayakawa H, Chida K.

Respirology. 2009 Mar;14(2):203-9. doi: 10.1111/j.1440-1843.2008.01457.x. Epub 2008 Dec 11.

PMID:
19210645
13.

Use of Induced sputum to determine the prevalence of Pneumocystis jirovecii in immunocompromised children with pneumonia.

Das CK, Mirdha BR, Singh S, Seth R, Bagga A, Lodha R, Kabra SK.

J Trop Pediatr. 2014 Jun;60(3):216-22. doi: 10.1093/tropej/fmt112. Epub 2014 Jan 13.

PMID:
24425204
14.

Combined quantification of pulmonary Pneumocystis jirovecii DNA and serum (1->3)-β-D-glucan for differential diagnosis of pneumocystis pneumonia and Pneumocystis colonization.

Damiani C, Le Gal S, Da Costa C, Virmaux M, Nevez G, Totet A.

J Clin Microbiol. 2013 Oct;51(10):3380-8. doi: 10.1128/JCM.01554-13. Epub 2013 Jul 31.

15.
16.

Prevalence of Pneumocystis jirovecii pneumonia (2010-2013): the first Croatian report.

Babic-Erceg A, Vilibic-Cavlek T, Erceg M, Mlinaric-Missoni E, Begovac J.

Acta Microbiol Immunol Hung. 2014 Jun;61(2):181-8. doi: 10.1556/AMicr.61.2014.2.8.

PMID:
24939686
17.

Differences in the clinical characteristics of Pneumocystis jirovecii pneumonia in immunocompromized patients with and without HIV infection.

Enomoto T, Azuma A, Kohno A, Kaneko K, Saito H, Kametaka M, Usuki J, Gemma A, Kudoh S, Nakamura S.

Respirology. 2010 Jan;15(1):126-31. doi: 10.1111/j.1440-1843.2009.01660.x. Epub 2009 Nov 23.

PMID:
19947989
18.

A highly sensitive novel PCR assay for detection of Pneumocystis jirovecii DNA in bronchoalveloar lavage specimens from immunocompromised patients.

Tia T, Putaporntip C, Kosuwin R, Kongpolprom N, Kawkitinarong K, Jongwutiwes S.

Clin Microbiol Infect. 2012 Jun;18(6):598-603. doi: 10.1111/j.1469-0691.2011.03656.x. Epub 2011 Sep 26.

19.

[Pneumocystis jiroveci pneumonia in immunocompromised patients without AIDS -- a case series].

Blum T, Roth A, Mauch H, Erbes R, Lode H.

Dtsch Med Wochenschr. 2006 Jul 7;131(27):1515-20. German.

PMID:
16817100
20.

Clinical utility of serum beta-D-glucan and KL-6 levels in Pneumocystis jirovecii pneumonia.

Nakamura H, Tateyama M, Tasato D, Haranaga S, Yara S, Higa F, Ohtsuki Y, Fujita J.

Intern Med. 2009;48(4):195-202. Epub 2009 Feb 16.

Items per page

Supplemental Content

Write to the Help Desk